Maximum Retail Prices of Medicines
.png)
.png)
Welcome to the official website of the National Medicine Regulatory Authority of Sri Lanka. We are dedicated to ensuring the safety and efficacy of medicines for the people of Sri Lanka.
The National Medicine Regulatory Authority of Sri Lanka is committed to ensuring the safety, efficacy, and quality of medicines in the country. We strive to protect public health by regulating the manufacturing, importation, distribution, and sale of medicines.
NMRA regulates medicines, medical devices, borderline products imported to and manufactured in Sri Lanka. We also regulate pharmacies. Clinical trials conducted in Sri Lanka are also regulated by us.
Find Out MoreNational Medicines Quality Assuarance of the NMRA is responsible for the analyzing of the quality of any medicine, medical device or borderline product forwarded by the Authority. It functions as an additional approved analyst when the circumstance so requires.
Find Out MorePharmacovigilance Division is responsible for monitoring and dealing with adverse drug reaction, quality failure and counterfeit medicines.
Find Out MoreInspectorate and Enforcement Division is responsible for inspecting and investigating issues pertaining to proper implementation of the provision of the NMRA Act.
Find Out MoreNational Medicines Regulatory Authority,
State Engineering Corporation Building (2nd Floor),
No. 130,
W.A.D Ramanayaka Mawatha,
Colombo 02,
Sri Lanka
NOTICE TO ALL AUTHORIZED LOCAL AGENTS.
Subject : Publishing the list of approved MRP Revisions due to currency depreciation.
This is to notify all Authorized Local Agents that the following is the finalized list of approved MRP revisions due to currency depreciation. Revision application forms reviewed up to 16-09-2026by the NMRA Pricing Division have been processed and the relevant applications have been forwarded to the NMRA Licensing Unit for further action. Please find the list below.
Accordingly, all concerned Authorized Local Agents are hereby requested to submit the relevant valid Import License(s) to the NMRA Licensing Unit without delay. Your prompt attention and cooperation in this regard are strongly requested to avoid any further delay in processing the applications.
Click Here : List of approved MRP Revisions due to currency depreciation.
The National Medicines Regulatory Authority (NMRA) invites dental medical device manufacturers, importers, distributors, and other relevant stakeholders to participate in
a Stakeholder Consultation Meeting to discuss current regulatory matters and challenges relating to dental medical devices.
Date: 09 September 2026
Time: 10:00 a.m.
Venue: NMRA Auditorium, 3rd Floor, No. 130, W. A. D. Ramanayake Mawatha,
Colombo 02.
Stakeholders are invited to participate and share their views and suggestions to support effective regulatory decision-making.
Dear All,
Medical Device applications will be accepted every Tuesday from 8:30 a.m. to 3:00p.m., commencing 25.08.2026.
Applicants are kindly requested to submit their applications only during the above-mentioned time period.
Medical Device Regulatory Division
NMRA- Sri Lanka
This is to formally notify all Market Authorization Holders (MAHs) that the documents previously submitted to the NMRA online system for the purpose of Manufacturing Plant Registration during the years 2019, 2020, and 2021 must now be submitted as a physical dossier.
Please note that this measure is strictly necessary due to the current unavailability of the NMRA database. Consequently, we are unable to trace the original online document submissions for the above period.
When submitting the physical dossier, please be advised that it is mandatory to attach,
Any MAHs who have not yet submitted their physical dossiers must ensure that they do so on or before 31st December 2026. Please note that the dossiers can only be submitted on every Thursdays.
We kindly request your prompt compliance with this requirement to facilitate the smooth processing of your registrations and to avoid any unnecessary delays.
CEO/NMRA
Notice to all Authorized Local Agents,
Average US Dollar Rate September -2026 for Price Approvals of MRP’s by NMRA
This is to kindly inform all authorized local agents that the USD rate considered for the month of September -2026 for processing price details of medicines/medical devices is 338.04.
Please ensure that all price submissions for MRP approvals are prepared accordingly.
